Search research articles
Contact Us
Filters
Showing results (31-40 of 55) with videos related to
Page
of 6
Sort By:
Journal of Personalized Medicine
|
June 27, 2024
Digenic Inheritance of Mutations in Homologous Recombination Genes in Cancer Patients
Maria Valeria Freire, Marie Martin, Karin Segers, et al.
Haematologica
|
November 8, 2011
t(X;14)(p11.4;q32.33) is recurrent in marginal zone lymphoma and up-regulates GPR34
Mathijs Baens, Julio Finalet Ferreiro, Thomas Tousseyn, et al.
Melanoma Research
|
May 12, 2018
The impact of patient characteristics and disease-specific factors on first-line treatment decisions for BRAF-mutated melanoma: results from a European expert panel study
Paolo A Ascierto, Lars Bastholt, Pier F Ferrucci, et al.
The Journal of Urology
|
December 5, 2012
A possible role for microRNA-141 down-regulation in sunitinib resistant metastatic clear cell renal cell carcinoma through induction of epithelial-to-mesenchymal transition and hypoxia resistance
Joost Berkers, Olivier Govaere, Pascal Wolter, et al.
Radiology. Imaging Cancer
|
April 5, 2021
Quantitative Whole-Body Diffusion-weighted MRI after One Treatment Cycle for Aggressive Non-Hodgkin Lymphoma Is an Independent Prognostic Factor of Outcome
Katja N De Paepe, Ciska-Anne Van Keerberghen, Giorgio M Agazzi, et al.
Oncotarget
|
April 15, 2015
Independent replication of a melanoma subtype gene signature and evaluation of its prognostic value and biological correlates in a population cohort
Jérémie Nsengimana, Jon Laye, Anastasia Filia, et al.
Acta Clinica Belgica
|
May 25, 2018
ABCG2 Polymorphism rs2231142 and hypothyroidism in metastatic renal cell carcinoma patients treated with sunitinib
Emilie Werbrouck, Julie Bastin, Diether Lambrechts, et al.
Cancer
|
March 29, 2014
A randomized, open-label clinical trial of tasisulam sodium versus paclitaxel as second-line treatment in patients with metastatic melanoma
Omid Hamid, Robert Ilaria, Claus Garbe, et al.
International Journal of Cancer
|
November 18, 2014
MGMT promoter methylation is associated with temozolomide response and prolonged progression-free survival in disseminated cutaneous melanoma
Rainer Tuominen, Rosalyn Jewell, Joost J van den Oord, et al.
Acta Clinica Belgica
|
May 19, 2018
Prospective evaluation of hypogonadism in male metastatic renal cell carcinoma patients treated with targeted therapies
Julie Bastin, Emilie Werbrouck, Annelies Verbiest, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 55) with videos related to
Sort By:
Page
of 6
Journal of Personalized Medicine
|
June 27, 2024
Digenic Inheritance of Mutations in Homologous Recombination Genes in Cancer Patients
Maria Valeria Freire, Marie Martin, Karin Segers, et al.
Haematologica
|
November 8, 2011
t(X;14)(p11.4;q32.33) is recurrent in marginal zone lymphoma and up-regulates GPR34
Mathijs Baens, Julio Finalet Ferreiro, Thomas Tousseyn, et al.
Melanoma Research
|
May 12, 2018
The impact of patient characteristics and disease-specific factors on first-line treatment decisions for BRAF-mutated melanoma: results from a European expert panel study
Paolo A Ascierto, Lars Bastholt, Pier F Ferrucci, et al.
The Journal of Urology
|
December 5, 2012
A possible role for microRNA-141 down-regulation in sunitinib resistant metastatic clear cell renal cell carcinoma through induction of epithelial-to-mesenchymal transition and hypoxia resistance
Joost Berkers, Olivier Govaere, Pascal Wolter, et al.
Radiology. Imaging Cancer
|
April 5, 2021
Quantitative Whole-Body Diffusion-weighted MRI after One Treatment Cycle for Aggressive Non-Hodgkin Lymphoma Is an Independent Prognostic Factor of Outcome
Katja N De Paepe, Ciska-Anne Van Keerberghen, Giorgio M Agazzi, et al.
Oncotarget
|
April 15, 2015
Independent replication of a melanoma subtype gene signature and evaluation of its prognostic value and biological correlates in a population cohort
Jérémie Nsengimana, Jon Laye, Anastasia Filia, et al.
Acta Clinica Belgica
|
May 25, 2018
ABCG2 Polymorphism rs2231142 and hypothyroidism in metastatic renal cell carcinoma patients treated with sunitinib
Emilie Werbrouck, Julie Bastin, Diether Lambrechts, et al.
Cancer
|
March 29, 2014
A randomized, open-label clinical trial of tasisulam sodium versus paclitaxel as second-line treatment in patients with metastatic melanoma
Omid Hamid, Robert Ilaria, Claus Garbe, et al.
International Journal of Cancer
|
November 18, 2014
MGMT promoter methylation is associated with temozolomide response and prolonged progression-free survival in disseminated cutaneous melanoma
Rainer Tuominen, Rosalyn Jewell, Joost J van den Oord, et al.
Acta Clinica Belgica
|
May 19, 2018
Prospective evaluation of hypogonadism in male metastatic renal cell carcinoma patients treated with targeted therapies
Julie Bastin, Emilie Werbrouck, Annelies Verbiest, et al.
Page
of 6